Nanostructure of cationic lipid-oligonucleotide complexes

Biophysical Journal
Sarah WeismanYeshayahu Talmon

Abstract

Complexes (lipoplexes) between cationic liposomes and single-strand oligodeoxynucleotides (ODN) are potential delivery systems for antisense therapy. The nanometer-scale morphology of these assemblies is relevant to their transfection efficiency. In this work the monocationic lipid dioleoyloxytrimethylammoniumpropane, the neutral "helper" lipid cholesterol, and an 18-mer anti-bcl2 ODN were combined at different ratios. The lipoplexes formed were characterized for the quantity of ODN bound, for the degree of lipid mixing, and for their size. The nanostructure of the system was examined by cryogenic-temperature transmission electron microscopy, augmented by small-angle x-ray scattering. Addition of ODN to cationic liposomes induced both liposome aggregation and the formation of a novel condensed lamellar phase. This phase is proposed to be stabilized by anionic single-strand ODN molecules intercalated between cationic bilayers. The proportion of cholesterol present apparently did not affect the nature of lipoplex microstructure, but changed the interlamellar spacing.

References

Sep 1, 1988·Journal of Electron Microscopy Technique·J R BellareY Talmon
May 4, 1995·Biochimica Et Biophysica Acta·J GustafssonM Almgren
Jul 1, 1997·Nature Biotechnology·N S TempletonG N Pavlakis
Aug 22, 2001·Lancet·I TammG Hartmann
Oct 24, 2001·Current Opinion in Oncology·K T FlahertyP J O'Dwyer
Jun 28, 2002·International Journal of Pharmaceutics·Crispin R Dass

❮ Previous
Next ❯

Citations

Apr 15, 2010·Journal of the American Chemical Society·Alexander A YaroslavovFredric M Menger
Apr 19, 2008·The Journal of Physical Chemistry. B·Claire L PizzeyYeshayahu Talmon
May 3, 2011·Langmuir : the ACS Journal of Surfaces and Colloids·Sharon GolanYeshayahu Talmon
Aug 30, 2011·Langmuir : the ACS Journal of Surfaces and Colloids·Marie BretonNathalie Mignet
Dec 14, 2011·Molecular Pharmaceutics·Chenguang ZhouRobert J Lee
Sep 4, 2009·Molecular Pharmaceutics·Wanlop WeecharangsanRobert J Lee
May 1, 2013·International Journal of Nanomedicine·Satya Ranjan SarkerShinji Takeoka
Mar 4, 2015·Advanced Drug Delivery Reviews·Yuhua WangLeaf Huang
Oct 8, 2011·International Journal of Pharmaceutics·Mamta KapoorSiddhesh D Patil
Feb 12, 2011·International Journal of Pharmaceutics·Judith KuntscheHeike Bunjes
Dec 29, 2009·Journal of Controlled Release : Official Journal of the Controlled Release Society·Wassana WijagkanalanMitsuru Hashida
Dec 24, 2015·Biomaterials·Yuqiong XiaXiaoyuan Chen
Mar 24, 2007·Nanomedicine : Nanotechnology, Biology, and Medicine·Barbara RuoziMaria Angela Vandelli
Aug 1, 2015·Acta Biomaterialia·Ana C N OliveiraKevin Braeckmans
Sep 17, 2015·Langmuir : the ACS Journal of Surfaces and Colloids·Thais L NascimentoElias Fattal
Jul 30, 2005·Biochimica Et Biophysica Acta·Danielle Hirsch-LernerYechezkel Barenholz
Dec 26, 2006·Journal of Controlled Release : Official Journal of the Controlled Release Society·K RemautS C De Smedt
Nov 22, 2005·Journal of Controlled Release : Official Journal of the Controlled Release Society·K RemautS C De Smedt
Sep 26, 2013·Biochimica Et Biophysica Acta·Bruno F B SilvaCyrus R Safinya
Dec 15, 2010·Biochimica Et Biophysica Acta·Julio H K RozenfeldAna M Carmona-Ribeiro
Jun 27, 2013·Biochimica Et Biophysica Acta·Begoña Ugarte-UribeItziar Alkorta
Oct 2, 2013·Colloids and Surfaces. B, Biointerfaces·Fernanda BruxelHelder F Teixeira
Aug 9, 2011·Biochimica Et Biophysica Acta·Catarina MadeiraManuel Prieto
Dec 30, 2014·Journal of Controlled Release : Official Journal of the Controlled Release Society·Stefano ColomboCamilla Foged
Feb 6, 2017·Colloids and Surfaces. B, Biointerfaces·Tiago A BalbinoLucimara G de la Torre
Jun 14, 2006·Advances in Colloid and Interface Science·Suzana Segota, Durdica Tezak
Feb 24, 2015·Physical Chemistry Chemical Physics : PCCP·Julio H K RozenfeldM Teresa Lamy
Jan 1, 2016·Nanomaterials·Virginia CampaniGiuseppe De Rosa
Jun 16, 2016·Food & Function·Marta Kinga LemieszekWojciech Rzeski
Apr 20, 2011·Nature Reviews. Endocrinology·Michael P CzechGregory J Tesz
Jan 12, 2010·Journal of Internal Medicine·A SchroederD G Anderson
Sep 25, 2019·Current Pharmaceutical Biotechnology·Tianzhong LiMengsu Yang
Dec 18, 2008·Physical Chemistry Chemical Physics : PCCP·Giacomo Martini, Laura Ciani

❮ Previous
Next ❯

Related Concepts

Related Feeds

BCL-2 Family Proteins

BLC-2 family proteins are a group that share the same homologous BH domain. They play many different roles including pro-survival signals, mitochondria-mediated apoptosis and removal or damaged cells. They are often regulated by phosphorylation, affecting their catalytic activity. Here is the latest research on BCL-2 family proteins.